Grifols (GIFLF) Net Margin Growth (3y) (2013 - 2024)
Powered by 
Analysis
Grifols (GIFLF) Net Margin Growth (3y) (2013 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 388.00 |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | -15,026.00 |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | -374.00 |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | -44.00 |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 6,620.00 |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | -13,815.00 |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 9,934.00 |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | -2,059.00 |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -1.86 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 48,517.00 |
| Dec 31, 2021 | -50,711.00 |
| Dec 31, 2020 | -56,354.00 |
| Mar 31, 2020 | 121.00 |
| Dec 31, 2019 | 1,229.00 |
| Mar 31, 2019 | -1,464.00 |
| Dec 31, 2018 | 966.00 |
| Jun 30, 2018 | 260.00 |
| Mar 31, 2018 | 687.00 |
| Dec 31, 2017 | 1,767.00 |
| Jun 30, 2017 | -6.00 |
| Mar 31, 2017 | 676.00 |
| Dec 31, 2016 | -47,817.00 |
| Sep 30, 2016 | 151.00 |
| Jun 30, 2016 | 85.00 |
| Mar 31, 2016 | 1,615.00 |
| Dec 31, 2015 | -34,211.00 |
| Sep 30, 2015 | 2,145.00 |
| Jun 30, 2015 | 70.00 |
| Mar 31, 2015 | 2,131.00 |